Indianapolis, IN, United States of America

Linda H Malkas

This inventor holds 15 USPTO granted patents and 12 published patent applications, plus 4 CIPO patents and 6 EPO patents. Top assignees: Beckman Research Institute, City of Hope, Cs-Keys, Inc., Indiana University. Active years: 2007-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Linda H Malkas. Retrieved from https://idiyas.com/inventor/linda-h-malkas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 12)

% Patents Active = 93.3

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 16(Granted Patents)

Location History:

Indianapolis, IN (US) (2007 - 2016)
Lakeview Terrace, CA (US) (2015 - 2019)
Duarte, CA (US) (2020 - 2024)

Company Filing History:

5 out of 692

Beckman Research Institute, City of Hope

5. 5 out of 834,570

Other

patents

Years Active: 2007-2025

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12435030 - PCNA inhibitors (2025-10-07),

2. 12054447 - PCNA inhibitors (2024-08-06),

3. 11345656 - PCNA inhibitors (2022-05-31),

4. 10913706 - PCNA inhibitors (2021-02-09),

5. 10550070 - PCNA inhibitors (2020-02-04),

6. 10420840 - Anticancer therapeutic agents (2019-09-24),

7. 10188699 - CAPCNA peptide therapeutics for cancer (2019-01-29),

8. 9527895 - CAPCNA peptide therapeutics for cancer (2016-12-27),

9. 9187526 - Peptide based inhibition of caPCNA interaction in cancer (2015-11-17),

10. 9006396 - CsPCNA isoform antibodies and uses thereof (2015-04-14),

11. 8653039 - Peptide based inhibition of caPCNA interaction in cancer (2014-02-18),

12. 8278278 - Cell proliferation reducing cancer specific PCNA peptides (2012-10-02),

13. 7932023 - csPCNA isoform modifications and uses thereof (2011-04-26),

14. 7723487 - Method for purifying cancer-specific proliferating cell nuclear antigen (2010-05-25),

15. 7294471 - Method for purifying cancer-specific proliferating cell nuclear antigen (2007-11-13),

Title: Innovations and Contributions of Linda H. Malkas

Introduction

Linda H. Malkas is a prominent inventor based in Indianapolis, IN, known for her significant contributions to cancer research. With a total of 15 patents to her name, she has made remarkable strides in the field of medical science, particularly in the development of treatments aimed at combating cancer.

Latest Patents

Among her latest patents are innovative compositions of PCNA (Proliferating Cell Nuclear Antigen) modulators. These patents describe methods for treating or preventing cancer, showcasing her dedication to advancing cancer therapies. The focus on PCNA inhibitors highlights her commitment to finding effective solutions for this critical health issue.

Career Highlights

Throughout her career, Linda has worked with esteemed organizations, including City of Hope, where she has contributed to groundbreaking research. Her work has not only advanced scientific understanding but has also paved the way for new therapeutic approaches in oncology.

Collaborations

Linda has collaborated with notable colleagues, including Robert J. Hickey and David A. Horne. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Linda H. Malkas exemplifies the spirit of innovation in the field of cancer research. Her extensive patent portfolio and collaborative efforts underscore her impact on medical science and her commitment to improving patient outcomes.

Profile summary based on public USPTO records.